Columbia Research Enhanced Core ETF
RECS
5 hedge funds and large institutions have $18.8M invested in Columbia Research Enhanced Core ETF in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 5 → 5 (0)
4.44% less ownership
Funds ownership: 83.83% → 79.39% (-4.4%)
15% less capital invested
Capital invested by funds: $22.2M → $18.8M (-$3.36M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$112K |
| 2 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
+$46.9K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$20.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.24M |
| 2 |
Jane Street
New York
|
-$643K |
RECS Hedge Fund Activity: Q4 2021 in Review
5 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Core ETF (RECS) for Q4 2021, worth a combined $18.8M — down 15% from $22.2M a quarter earlier.
Fund positioning in RECS was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, adding an estimated $112K. The largest seller was Ameriprise, cutting an estimated $1.24M.
- 5 institutional investors held Columbia Research Enhanced Core ETF (RECS) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $18.8M of Columbia Research Enhanced Core ETF stock for Q4 2021, down 15% quarter-over-quarter.
- 0 funds opened new Columbia Research Enhanced Core ETF positions in Q4 2021 and 0 closed out.
- The largest Columbia Research Enhanced Core ETF buyer in Q4 2021 was Bank of America, an estimated $112K added.
- The largest Columbia Research Enhanced Core ETF seller in Q4 2021 was Ameriprise, an estimated $1.24M sold.
Based on aggregated 13F filings for Q4 2021.